To elucidate mechanisms of glucagon-induced bicarbonaterich choleresis, we investigated the effect of glucagon on ion transport processes involved in the regulation of intracellular pH (pH1) in isolated rat hepatocyte couplets. It was found that glucagon (200 nM), without influencing resting pH1, significantly stimulates the Cl-/HCO3 exchange activity.
Introduction
Glucagon, in the liver, exerts a number of metabolic effects such as inhibition of glycogen synthesis and stimulation of gluconeogenesis and glycogenolysis.
Moreover, glucagon, at physiological doses, induces a bicarbonate-rich choleresis in humans (1) as well as in many different animal species, including the guinea pig (2), dog (3) , and rat (4) . Mechanisms of glucagon choleresis are still unknown. It has been established recently (2) that glucagon choleresis: (a) is canalicular in origin as it is associated with an increased clearance of erythritol and is not influenced by bile ductule proliferation; (b) is mediated by the intracellular messenger cAMP but not by inositol phosphates nor by prostaglandin release; and (c) requires an intact microtubular system (colchicine sensitivity).
Bile salt-independent bile flow is the result of active solute transport followed by osmotic water flow in bile canaliculi (5 . Bicarbonate together with glutathione represents the main solute responsible for this fraction of bile flow (5) . The ion transport processes underlying basal or hormonal-stimulated bicarbonate secretion in the hepatocyte are currently under investigation. Recent progress has been made in studies exploring intracellular pH (pHi) regulation in isolated hepatocytes (6) (7) (8) . These studies identify the presence of an electroneutral Na+ -independent C1-/ HCO3-exchanger (7, 8) which functions as a counterpoint to the acid extruding systems (NaI/H' exchanger and Na'-HCO-symport) (6) and which has been detected recently in the hepatocyte apical domain of human liver (9) . The Cl-/ HCO3-exchanger is present in all the bicarbonate-secreting epithelia (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . In biliary epithelium for example, this exchanger, functionally coupled with apically located C1-channels, is stimulated by secretin, a hormone which induces a ductular bicarbonate-rich choleresis (18, 19) . The role of the Cl-/HCO-3 exchanger in the generation of bile salt-independent bile flow has been supported recently by studies in the isolated perfused rat liver, where stimulation of this exchanger by intracellular alkalinization is followed by a bicarbonate-rich choleresis (20) .
In an attempt to elucidate the mechanisms of glucagon choleresis, this study focuses on the effect of glucagon on the H+/ (acid extruder) was also stimulated by the hormone. We have also shown that glucagon stimulation of the Cl-/HCO-exchanger does not involve 5 '-nitro-2'-(3-phenylpropyl-amino) -benzoate (NPPB)-sensitive Cl-channels, is partially blocked by the microtubular inhibitor colchicine, and is completely inhibited by the protein kinase C agonist, PMA, which, however, significantly decreases the cAMP accumulation induced by the hormone.
Methods
Materials. Glucagon, collagenase A, bovine serum albumin, EDTA, penicillin/streptomycin, heparin, Hepes, D( + )glucose, insulin, soybean trypsin inhibitor (type I-s), amiloride, DMSO, deoxyribonuclease (DN-25), nigericin, 4,4, diisothiocyano-2,2' disulfonic acid stilbene (DIDS), Na+-gluconate, K+-gluconate, hemicalcium gluconate, N6, 2 '-O-dibutyryladenosine-3 '-5 '-cyclic monophosphate (DBcAMP) , forskolin, PMA, and 3-isobutyl-1-methyl-xanthine (IBMX) were purchased from Sigma Chemical Co. (St. Louis, MO). 2,7,bis(carboxyethyl)-5(6)-carboxy-fluorescein-acetomethylester (BCECF-AM) was obtained from Molecular Probes, Inc. (Eugene, OR). Liebowitz 15 (L-15), MEM, a-MEM, L-glutamine, gentamicin, and fetal calf serum were obtained from Gibco Laboratories (Grand Island, NY). NPPB was provided by Prof. R. Greger (Freiburg, Germany). Rp-adenosine-3 ',5 '-monophosphothioate (Rp-cAMPS) was purchased from BioLog (Bremen, Germany) . N- [2- (p-bromocinnamyl-amino)ethyl]-5-isoquinolinesulfonamide HCl (H-89) was purchased from Calbiochem-Novabiochem (San Diego, CA).
cAMP[ 1251I] assay system was purchased from Amersham International (Little Chalfont, United Kingdom).
Isolation of rat hepatocyte couplets. Male Wistar rats (F. Morini, Reggio Emilia, Italy), weighing 240-260 grams, were housed in temperature-and light-controlled rooms and allowed free access to water and laboratory chow. Animals received humane care and the study protocol was in compliance with our institution's ethical guidelines.
LRHC were prepared by a modification (21) of Seglen's procedure (22) . The animals were anesthetized with pentobarbital (50 mg/kg intraperitoneally). The portal vein was cannulated by a 16-gauge cannula, and the liver was perfused in situ for 7 min with Ca2+, Mg2+-free Hanks' medium (NaCl 120 mM, KCl 5.0 mM, NaHCO3 25 mM, KH2PO4 0.66 mM, Na2HPO4 0.33 mM, 0.1% D-glucose) and then with Ca2 , Mg2+ containing Hanks' buffer supplemented with 0.05% collagenase A plus 0.8 U trypsin inhibitor/U of collagenase tryptic activity. When the capsula began to detach, the liver was removed from the carcass, grasped at the hilum by forceps, and the hepatocytes were combed into L-15 medium at 0°C. Cell suspension was then sequentially filtered through 80 (18, 23, 24) . Cells on glass coverslips were loaded with BCECF-AM (12 ,am) for 10 min, washed for 10 min in a BCECF-free medium, and transferred into a thermostated perfusion chamber placed on the stage of a Nikon Diaphot inverted microscope. The perfusion media were constantly warmed at 370C and gassed both by direct bubbling and by an artificial lung. For the experiments performed in HCO--enriched media, gas-impermeable tubing was used. Coverslips were scanned under DIC optics and an isolated couplet with a well developed canalicular pole was selected. Couplets with membrane blebs were avoided. Signal recording was obtained from one of the two hepatocytes constituting the couplet by using a pin hole device (Nikon) inserted in the emission light pathway. The microscope was connected with a rotating chopper mirror able to rapidly alternate the light generated by a 150 W xenon lamp between two excitation beams (490 and 440 nm). Light was attenuated to 0.1% by heat reflectors and neutral density filters (Omega Optics, Eugene, OR). The emitted light was read at 530 nm, integrated by the computer with 500-ms acquisitions every 1,500 ms and displayed in real time. All measurements for each excitation wavelength were corrected for background fluorescence obtained from dye-free cells. Fluorescence intensity exceeded background autofluorescence by at least 30-fold. The 490/440 fluorescence intensity ratio data were converted to pHi values by using the nigericin ( 12 /m) calibration curve technique (6-8, 18, 23-25) . Over the pH range of 6.4-7.7, fluorescence varied in a linear fashion with pHout.
Total and intrinsic intracellular buffering power. The intrinsic buffering power (/i) was determined at different pHi as described (7, 18, 24, (26) (27) (28) (29) (30) , by exposing the cells to 25 mM NH4Cl in Hepes, Na'-free buffered solutions and then decreasing the NH4C1 concentration by 5 or 10 mM for each step to 0 mM (n = 10). The Pi was then calculated from the midpoint change in pHi at each step. Pi values were then plotted versus pH, using a best-fit program (Enzfitter). /i/pH1 curves were also evaluated in IRHC perfused with 200 nM glucagon (n = 8).
As in other studies (7, 18, 24) Table I ). These findings further confirm that glucagon has no effect on the activity of the Na + /H + exchanger, evaluated at either basal pHi (amiloride effect on basal pH1) or at acid pHi values (recovery from an acute acid load).
Experiments in bicarbonate-containing media. The basal pHi of IRHC cultured and perfused with media supplemented with 25 mM HCO-(7.20±0.07, n = 72), was higher (P < 0.001) than in the nominal absence of HCO , indicating that a HCOloading mechanism is active. Exposure for 10 min to 200 nM glucagon (n = 10), 500 nM glucagon (n = 5), 200 nM glucagon + 100 IsM IBMX (n = 5) showed no detectable changes in basal pHi. Basal pHi also remained unchanged when glucagon was administered in cells perifused in HCO--containing media, with amiloride to inhibit the Na+/H+ exchanger (n = 6), thus excluding the involvement of this acid extruder as a mechanism of pHi maintenance during glucagon exposure. Effect of glucagon and DBcAMP + forskolin on Cl-1 HCO3 exchange (Table II, Fig. 1 ). The activity of the C1-/ HCO-exchanger was measured in IRHC, cultured and perfused with HCO --enriched media, by using the method of acute external C1-removal/readmission (7, 8, 18, 24, (27) (28) (29) (30) . Acute Cl removal (equimolar substitution with gluconate) produces an intracellular alkalinization due to the exit of internal Cl -in exchange with external HCO -, pH, recovering to baseline when external C1-is readmitted to drive the exchanger in the opposite direction. The net pHi increase promoted by Cl-removal (8pHi) and the rate of both pHi increase after Cl -removal and pHi recovery after Cl -readmission were the parameters measured to evaluate the activity of the Cl /HCO-exchanger. The effect of Cl -removal was completely abolished by 0.5 mM DIDS pretreatment (40-60 min of preincubation; n = 6) indicating that the increase in pHi induced by acute Cl -removal depends on the transport of HCO -across the cell membrane. When two consecutive Cl-removal/readmission maneuvers were performed no significant difference was found in the three measured parameters (n = 10). To evaluate the effect of glucagon, a second C1-removal/readmission maneuver was performed during superfusion with the hormone (200 nM; n = 10) and findings compared with those obtained after the first (control) maneuver. During glucagon perfusion, the net pHi increase (0.28±0.04 pH U) and the maximal rate of alkalinization (0.145±0.025 pH U/min; H+ flux = 7.78±1.58 mM/min) in- duced by Cl-removal were significantly (P < 0.02) higher then control values (Table II , Fig. 1 ). Glucagon also increased (P < 0.05) the rate of pHi recovery after Cl -readmission (Table II , Fig. 1 ). This demonstrates that glucagon stimulates the activity of the Cl /HCO-exchanger. Fig. 2 ). Cells were preincubated (30 min) and perfused with 10 1M Rp-cAMPS (n = 10) or with 30 AtM H-89 (n = 10). Two consecutive Cl-removal/readmission maneuvers were then performed, the second during superfusion with 200 nM glucagon. The effect of protein kinase A inhibitors on the basal (first Cl-removal/readmission maneuver) and on the glucagon-stimulated (second maneuver) Cl-/HCO-exchange activity was evaluated in comparison (ANOVA) with control experiments performed in the absence of inhibitors, but with glucagon superfusion during the second Cl-removal/readmission maneuver (Table III, Fig. 2) .
IRHC pretreated and perfused with Rp-cAMPS or with H-89 showed a basal activity of the Cl-/HCO3 exchanger (first Cl-removal/readmission maneuver) similar to controls (n = 12). In fact, the net pHi increase and the rate of alkalinization after Cl-removal as well as the rate of pH, recovery after Clreadmission were unchanged either by Rp-cAMPS or by H-89. In contrast, both Rp-cAMPS and H-89 significantly inhibited the glucagon-stimulated Cl-/HCO-exchange activity. In fact, when glucagon was administered (second C1-removal/readmission maneuver), the net pH, increase and the rate of alkalinization after C1 -removal as well as the rate of pHi recovery after Cl -readmission were significantly lower in IRHC pretreated and perfused with Rp-cAMPS (P < 0.03) or with H-89 (P < 0.02) in comparison with the corresponding parameters measured in control IRHC. Glucagon increased by 106% the basal rate of alkalinization induced by Cl -removal (P < 0.01 ) and by 66% the basal rate of pH, recovery after Cl -readmission (P < 0.02) in control IRHC. In contrast, glucagon increased the basal rate of alkalinization induced by C1-removal by only 36% (P < 0.05) in Rp-cAMPS-treated IRHC while no significant increase was found in H-89-treated cells. The rate of pHi recovery after Cl-readmission was unchanged by glucagon in either Rp-cAMPS-or H-89-treated cells. When two consecutive Cl-removal/readmission maneuvers were performed in IRHC pretreated and perfused with RpcAMPS (n = 6) or with H-89 (n = 6) but without glucagon administration, no significant differences were found in the three measured parameters between the first and the second maneuver.
Effect of the Cl-channel blocker, NPPB, on the glucagon stimulation of the ClU/HCO j exchanger activity (Table IV, Fig. 3 ). Since the activity of Cl-/HCO-exchangers may be regulated either by a direct effect of second messengers on the transporter or, indirectly, by modifying the rate of Cl-flux across Cl -channels in the cell membrane as described in other epithelia (11-15, 19, 32, 33) , the effect of NPPB, a specific and potent Cl -channel blocker (34), on the glucagon response in IRHC was assessed. NPPB alone showed no effect on the activity of the CI HCO-exchange. In fact, when two consecutive Cl-removal/readmission maneuvers were performed, the second in the presence of 10 AM NPPB, no differences in the pHi changes induced by Cl-removal/readmission were found (n = 7, Table IV). To evaluate the effect of NPPB on the glucagon stimulation of the Cl /HCO -exchange, after the first control maneuver, cells were superfused with 10 A.M NPPB and 2 min later with NPPB + glucagon (n = 7; Table IV, Fig. 3) . Even in the presence of NPPB, glucagon stimulates (P < 0.02) the net pHi increase after Cl-removal (0.27±0.05 pH U), the rate of alkalinization after Cl-removal (0.157±0.052 pH U/ min; H+ flux = 9.34±3.16 mM/min) and the rate of pHi recovery after Cl-readmission (0.197±0.089 pH U/min; H+ flux = 13.40±6.59 mM/min) with respect to the control values (first maneuver; Table IV, Fig. 3 ). These findings indicate that NPPB does not influence the glucagon stimulation of the Cl -/ HCO-exchanger, suggesting that the hormonal effect is not mediated by NPPB-sensitive Cl-channels.
Effect of PMA on the glucagon stimulation of Cl-/HCO3 exchanger (Table IV, Fig. 3 ). To evaluate the role of protein kinase C on the basal and glucagon-stimulated Cl/HCO -exchange, we investigated the effect of the agonist PMA on the pHi changes promoted by Cl-removal/readmission in the absence of or during glucagon exposure. PMA alone showed no effect on the activity of the Cl-/HCO-exchanger. In fact, when two consecutive Cl-removal/readmission maneuvers were performed, the second in the presence of 10 jLM PMA, no significant differences in the pHi changes induced by Clremoval/readmission were found (n = 7, Table IV ). To evaluate the effect of PMA on the glucagon stimulation of the Cl-/ HCO3-exchange, at the end of the first control maneuver, cells were superfused with 10 uM PMA and 4 min later with PMA + glucagon. A second Cl -removal/readmission maneuver was then performed and findings compared with the first control maneuver (n = 13; Table IV, Fig. 3 ). During superfusion with glucagon + PMA, the net pHi increase after Cl-removal (0.22±0.05 pH U), the rate of alkalinization after Cl-removal (0.070±0.034 pH U/min; H+ flux = 3.98±1.02 mM/min) and the rate of pHi recovery after Cl-readmission (0.130±0.063 pH U/min; H+ flux = 7.05±3.17 mM/min) were similar to control values (first control maneuver; Table IV; Fig. 3 ). These findings indicate that PMA blocks the glucagon stimulation of the activity of the Cl-/HCO-exchanger.
Effect ofcolchicine on the glucagon stimulation of the Cl-I HCO-exchanger activity (Table IV, Fig. 4) . To evaluate the role of the microtubular system on the basal and glucagonstimulated Cl IHCO-exchange activity, IRHC were pretreated with the microtubular inhibitor colchicine ( 10-5 M) or with its inactive analogue, /3-lumicolchicine ( I0-5 M), for 4-5 h. Two consecutive Cl-removal/readmission maneuvers were then performed, the second during superfusion with 200 nM glucagon. Colchicine pretreatment (n = 10) significantly (P < 0.03) decreased the net pHi increase (0.12±0.04 pH U) and the rate of alkalinization after Cl-removal (0.040±0.018 pH U/min; H' flux = 2.20±0.77 mM/min) as well as the rate of pH, recovery after Cl-readmission (0.054±0.014 pH U/min; H' flux = 3.36±0.92 mM/min) in comparison with 3-lumicolchicine-pretreated cells (n = 10; Table IV, Fig. 4) Effect ofglucagon on the activity ofthe Na +-HCO3 symport (Table I, Fig. 5 ). The activity of the Na'-HCO-symport was measured by evaluating the rate of recovery from 20 mM NH4Cl pulse in cells cultured and perfused with HCOenriched media. This recovery is driven by two acid extruder mechanisms, the Na+/H' exchanger and the Na'-HCO-3 symport (6) . To exclude the influence of the Na+/H' exchanger, when NH4Cl was withdrawn, cells were perfused with 1 mM amiloride. When two consecutive NH4Cl-amiloride pulses were performed (n = 7), no differences in the degree of acidification (nadir pHi) and in the maximal rate of pHi recovery from the acid load were found. To investigate the effect of glucagon, a second NH4Cl-amiloride pulse was performed during glucagon exposure, and the maximal rate of pH, recovery was compared with the first control pulse (n = 8; Table I , Fig. 5 ). Both the degree of acidification (nadir pH, = 6.70±0.08) and the maximal rate of recovery from NH4C--amiloride pulse in the presence of glucagon were similar to the values measured in the absence of glucagon (nadir pHi = 6.69+0.07), indicating that the hormone has no effect on the activity of the Na'-HCO3 symport measured at acid pHi values. The Na'-HCO3 symport activity and the effect of glucagon were also evaluated at pHi values approaching the basal pH, of IRHC and in conditions where Na+/H+ and Cl-/HCO-exchangers were blocked. For this purpose, cells were preincubated (40 min) and perfused with Cl--free media (equimolar substitution with gluconate). In these experimental conditions, IRHC showed a higher (P < 0.01) basal pHi (7.40±0.07) in comparison with cells incubated and perfused with media containing normal Cl-concentration, due to the blockade of the acid loader Cl-/HCO-exchanger. When Cl--depleted IRHC were submitted to a 15 mM NH' acid pulse and amiloride was administered at the moment of NH' withdrawal, nadir acidification (7.12±0.02) was close to the basal pH, of IRHC in medium containing normal C1-concentration (7.19±0.07). If H2-DIDS (0.5 mM) was administered together with amiloride at the moment of NH'T withdrawal (n = 4), the recovery from the acid load was completely abolished, indicating that the entrance of HCO-is responsible for this pHi recovery.
Two consecutive 15 mM NH' pulses were performed, the second during glucagon exposure and, at the moment of NH'4 withdrawal, amiloride was superfused to exclude the influence of the Na+/H+ exchanger (n = 8; Table I 
Discussion
Ion transport processes involved in pHi regulation have been defined previously in rat hepatocyte subconfluent monolayers (6) (7) (8) . In our study, pHi measurement was performed in polarized IRHC, using a single cell microfluorimetric equipment. This method has the advantage of recording the signal from a polarized cell system, which represents the functional secretory unit in the liver (5) , rather than averaging the signal from a whole cell population, containing either polarized or nonpolarized cells. Furthermore, viability of IRHC was considerably higher than the whole cell population and was less variable between different cell preparations. Consistent with the above, the activities of transport processes involved in pH, regulation measured in IRHC were higher than those reported in subconfluent rat hepatocyte monolayers (6) (7) (8) .
Effect of glucagon on the C1-JHCO-exchanger activity. In all the cell types studied (7, 8, 11-15, 18, 24, 27-30) , the C1-/HCO exchanger has been shown to work as an acid loader driven by the Cl -gradient. As an acid loader, this exchanger functions as a counterpoint to the acid extruder systems in the pHi regulation on hepatocytes (6) (7) (8) . The Cl-/HCO-exchanger was first identified in canalicular rat liver plasma membrane vesicles (35) , then in monolayer culture of isolated hepatocytes (7) and recently it has been detected immunohistochemically in the hepatocyte apical domain of human liver (9) . The two acid extruders, Na'-HCO-symport and Na+/H+ exchanger, in addition to isolated rat hepatocytes (6), have also been identified in rat hepatocyte basolateral membrane vesicles (36, 37) . It could thus be assumed that in the polarized IRHC, the CP-/HCO-exchanger is located on the apical side and the two acid extruders are located on the basolateral side. Electrophysiological studies on IRHC have demonstrated that the resistances of tight junctions that seal the canalicular lumen from the bathing media are comparable with those of leaky epithelia and allow rapid ion equilibration between these two compartments (38) . This implies that the behavior of the Cl-/HCO3 in response to Cl -removal/readmission from the bathing media should be the same whether the exchanger is restricted to the canalicular domain of IRHC or not.
In the isolated perfused rat liver, stimulation of Cl-/ HCO-exchanger by intracellular alkalinization induces a bicarbonate-rich choleresis, thereby suggesting the involvement of Cl-removal/readmission maneuver was then performed (n = 13).
During superfusion with glucagon + PMA, the net pHi increase and the rate of alkalinization after Cl -removal as well as the rate of pH; recovery after Cl -readmission were similar with respect to control values.
this exchanger in bicarbonate excretion in bile and in the generation of bile salt-independent canalicular bile flow (20) . We demonstrated that glucagon stimulates the activity of the Cl-/ HCO3-exchanger, a mechanism which could sustain the bicarbonate-rich choleresis induced by this hormone. Glucagon increased the rate of CP-/HCO exchange by 100% when meastred during Cl -removal or by 50% after Cl -readmission. In comparison, the excretion rates of bicarbonate in bile were increased by 34% in the rat (4) and by 71% in the guinea pig (2) . A number of studies have shown previously that glucagon, after stimulation of adenylate cyclase activity, increased the intracellular level of cAMP in isolated rat hepatocytes (31) , in the isolated perfused rat (39) , and in guinea pig liver (2) . By extrapolating measurements of the entire preparation of isolated rat hepatocytes, the concentration of glucagon used to stimulate the Cl/HCO-exchange in IRHC induces an almost maximal increase of cAMP levels. That cAMP is the intracellular messenger mediating the glucagon-induced bicarbonate biliary excretion was shown previously in the isolated perfused guinea pig liver (2) , where a bicarbonate-rich choleresis was induced by glucagon but not by a glucagon analogue, TH-glucagon, which did not increase the intracellular level of cAMP. In addition, in the perfused rat liver, DBcAMP induced a bicarbonaterich choleresis (40). Our finding that DBcAMP + forskolin completely mimics the stimulatory effect of glucagon on CP-/ HCO-exchange strongly suggests that this hormone enhances the bicarbonate excretion in bile via cAMP-mediated stimulation of an apically located (9) Cl-/HCO3-exchanger. This is in keeping with studies concerning a number of different bicarbonate-secreting epithelia, where the intracellular messenger cAMP appears to stimulate the HCO -excretion mediated by the Cl-/HCO-exchanger (10-13, 17, 18) . We then investigated the involvement of protein kinase A in the glucagon stimulation of the Cl-/HCO -exchanger activity using two different protein kinase A inhibitors, Rp-cAMPS and H-89. Rp-cAMPS is a distereomer of an analogue of natural cAMP which binds to the regulatory subunit of both type I and type H cAMPdependent protein kinase without dissociating the catalytic subunit (41) . Rp-cAMPS is also a poor substrate for several phosphodiesterases (42) . In rat hepatocytes, Rp-cAMPS inhibited glucagon-induced glycogenolysis, a cAMP-mediated effect (43 involved in glucagon stimulation of the exchanger. Different Cl -channels could, however, be involved also in light of a recent description, in rat liver canalicular plasma membranes, of two types (30-and 90-pS conductance) of Cl-channels with NPPB-insensitive conductance and kinetics (45) . In different cell types, several ion transport systems regulated by protein kinase A show inverse sensitivity to protein kinase C (46, 47) . In the isolated perfused rat liver, protein kinase C agonists, phorbol esters, inhibit DBcAMP-stimulated bile flow (48) and, in isolated rat hepatocytes, they inhibit the HCO -and DBcAMP-stimulated Cl-/HCO-exchanger activity (8) . This prompted us to explore the role of protein kinase C in the glucagon stimulation of the Cl /HCO -exchanger. We demonstrated that the phorbol ester, PMA, completely blocked Effect of Glucagon on pHi Regulation in Isolated Rat Hepatocyte Couplets 673 --4 i I the effect of glucagon on Cl-/HCO-exchanger activity but, however, this effect was achieved through a marked inhibition of the glucagon-induced cAMP accumulation in isolated hepatocytes. Although an additional effect at the level of the Cl -/HCO exchanger cannot be excluded, our findings are consistent with a counterregulatory effect of protein kinase C, or PMA itself, at the level of glucagon receptors or adenylate cyclase. This is in keeping with previous studies showing that phorbol esters cause a dose-dependent inhibition of the glucagon-stimulated adenylate cyclase in plasma membranes isolated from rat hepatocytes, probably through protein kinase C activation and modification of the guanine nucleotide regulatory protein system (49).
The microtubular system is thought to be involved in many different transport processes in the liver as well as in the generation of bile flow (5) . As far as glucagon choleresis is concerned, this is blocked by the microtubular inhibitor colchicine, which did not interfere with the metabolic effects or cAMP accumulation induced by the hormone (2). We found that both basal and glucagon-stimulated Cl-/HCO-exchange activities were inhibited by colchicine in comparison with P-lumicolchicine.
However, in colchicine-treated cells, a glucagon stimulation of Cl fHCO-exchanger is still present, although at a lower level than in ,l-lumicolchicine controls. The effect of colchicine occurred without influencing the glucagon-induced cAMP accumulation in isolated hepatocytes. These findings could be explained by the fact that the number of Cl-/HCO-units in the canalicular membranes was decreased by colchicine through a blockade of a microtubular-dependent targeting of vesicles containing the exchanger to the canalicular plasma membranes. Such regulatory mechanisms of the Cl /HCO3-exchanger have been proposed (8) after observations that colchicine inhibits the stimulation of the Cl /HCO-exchanger induced by incubation of isolated hepatocytes in HCO--containing media.
Effect of glucagon on pHi regulation in IRHC. Despite the increased bicarbonate excretion via Cl -/HCO activation, glucagon showed no effect on basal pHi of IRHC. The maintenance of basal pHi, despite the increased bicarbonate excretion via Cl-/HCO-exchange stimulation, indicates that a compensatory mechanism in the cell is, in parallel, activated by glucagon. We investigated whether glucagon stimulation of the acid loading mechanism (Cl-/HCO-exchanger) is balanced by an increased activity of acid extruders. We have excluded an effect of glucagon on the Na+/H+ exchanger both when the activity of this acid extruder was measured at basal pHi (amiloride exposure withdrawal) and after an acute acid load. The other acid extruding system, Na'-HCO3 symport, was not stimulated by glucagon at acid pHi, as evaluated by the recovery rate from an acute acid load in KRB (20 mM NH4Cl) and in the presence of amiloride (nadir pH = 6.7). However, since the stimulatory effect of glucagon on the Cl /HCO-was demonstrated at basal pHi (Cl -removal) or at higher pH. values (Cl -readmission), we tried to use a protocol whereby the activity of the Na+-HCO-symport and the effect of glucagon could be measured at pHi values close to basal pHi of IRHC. Indeed, when we measured the recovery rate from a 15 mM NH4 acid load in Cl --depleted and amiloride-perfused IRHC (nadir pHi = 7.13) a significant stimulation by glucagon was observed. It was demonstrated previously, in Cl--depleted and amiloride-perfused hepatocyte monolayers, that the recovery from an acute acid load is driven by the Na'-HCO-symport (6), which is the major acid extruding mechanism in the presence of bicarbonate. Cl /HCO-exchanger activity in IRHC. The figure shows the two acid extruders (Na+-H + exchanger and Na+-HCO symport) located on the basolateral side and the acid loader (Cl-/HCO-exchanger) on the canalicular side of one of the two hepatocytes forming a couplet. BC, bile canaliculus. After binding to receptor (R), glucagon stimulates adenylate cyclase (AC) and enhances cAMP levels which, through protein kinase A (PKA), increases the activity of the apically located Cl -/HCO exchanger. Despite the glucagon-stimulated bicarbonate excretion, resting pHi of hepatocytes remains unchanged because of the parallel increase of bicarbonate loading through the stimulation of Na'-HCO-symport (dotted-line arrow). The Na+/H' exchanger was unaffected by glucagon.
We further observed how, in these experimental conditions, the pHi recovery from acid load is completely abolished by H2-DIDS, evidence that HCO-entrance is involved. Thus, our findings indicate that glucagon stimulates bicarbonate loading throughout the Na'-HCO-symport but that this takes place only at basal pHi and not at acid pHi values. A pH dependence of the Na'-HCO3 symport and of its regulation, demonstrated recently in basolateral membrane vesicles isolated from rabbit renal cortex (50) , could explain this finding. On the other hand, the glucacon stimulation of this symport occurred in Cl --depleted cells, a condition where the Cl -/HCO-exchanger is almost entirely blocked. This indicates that HCO-entrance is stimulated by the hormone independently and not as a consequence of increased bicarbonate extrusion via Cl /HCO exchanger. The Na'-HCO3 symport could be stimulated subsequent to the increased Na+ gradient induced by glucagon stimulation of (Na+-K+)-ATPase, an effect already demonstrated in isolated hepatocytes (51) .
The conclusions of our study are outlined in Fig. 7 . Glucagon enhances cAMP levels which in turn, through protein kinase A, stimulate the Cl/HCO-exchanger. This mechanism could account for in vivo induced bicarbonate-rich choleresis. Glucagon induces an upregulation of the pHi regulatory mechanisms operating in the presence of bicarbonate since the activity of the bicarbonate loading system, Na+-HCO3 symport, is also stimulated, thus avoiding changes of resting pHi. We have also shown that glucagon stimulation of the Cl-/HCO-exchange is not mediated by NPPB-sensitive chloride channels, requires an intact microtubule system, and is counterregulated by the protein kinase C agonist, PMA, which blocks the cAMP accumulation induced by the hormone.
From a physiologic point of view, molecular mechanisms of glucagon-induced bicarbonate excretion should mainly operate in the fasting state in relationship to the raised serum level of the hormone. In these conditions, the bicarbonate excretion stimulated by the hormone may well play an important role as an osmotic driving force for canalicular bile formation since bile salt biliary secretion is at the minimal rate.
